Get the Stockscreener App
0.00
2.94%
-0.102
Neximmune Inc stock is traded at $0.00, with a volume of 0.
It is down -2.94% in the last 24 hours and down -22.22% over the past month.
See More
Previous Close:
$0.102
Open:
$0
24h Volume:
0
Relative Volume:
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
$-20.62M
P/E Ratio:
0.00
EPS:
-18.54
Net Cash Flow:
$-17.61M
1W Performance:
-2.94%
1M Performance:
-22.22%
6M Performance:
-74.07%
1Y Performance:
+623.57%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$0.00
Neximmune Inc Stock (NEXI) Company Profile
Compare NEXI vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NEXI
Neximmune Inc
|
0.00 | 0 | 0 | -20.62M | -17.61M | -18.54 |
|
VRTX
Vertex Pharmaceuticals Inc
|
491.47 | 117.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
803.17 | 82.85B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
821.96 | 51.58B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
314.40 | 40.75B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.07 | 38.33B | 4.98B | 69.60M | 525.67M | 0.5198 |
Neximmune Inc Stock (NEXI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-01-21 | Initiated | Raymond James | Outperform |
| Mar-09-21 | Initiated | Barclays | Overweight |
| Mar-09-21 | Initiated | Cantor Fitzgerald | Overweight |
Neximmune Inc Stock (NEXI) Latest News
NexImmune Inc Is Exploding Online – But Is NEXI Stock a Hidden Gem or a Total Trap? - AD HOC NEWS
The Truth About NexImmune Inc: Why Everyone Is Suddenly Watching This Micro-Cap Wildcard - AD HOC NEWS
Contrasting NexImmune (OTCMKTS:NEXI) & Actinium Pharmaceuticals (NYSE:ATNM) - Defense World
NexImmune’s Vanishing Act: What Happens When a Ticker Survives but the Company Does Not? - AD HOC NEWS
Critical Survey: Endonovo Therapeutics (OTCMKTS:ENDVD) & NexImmune (OTCMKTS:NEXI) - Defense World
NexImmune, Inc.Common Stock (NQ: NEXI - FinancialContent
NexImmune (NEXI) Insider Trading Activity 2026 - MarketBeat
Sinovac says co receives Nasdaq notification regarding late filing of 2025 half-year report - marketscreener.com
Critical Comparison: NexImmune (OTCMKTS:NEXI) & Antibe Therapeutics (OTCMKTS:ATBPF) - Defense World
NexImmune (NEXI) Short Interest & Short Float | Updated Jan 2026 - MarketBeat
NexImmune (NEXI) Stock Chart and Price History 2026 - MarketBeat
NexImmune (NEXI) 10K Form and SEC Filings 2026 - MarketBeat
NexImmune (NASDAQ:NEXI) Stock Price Up 2,169,900% – Here’s Why - Defense World
Blank check company Abony Acquisition Corp. I files for IPOSEC filing - marketscreener.com
NexImmune (NASDAQ:NEXI) versus Avenue Therapeutics (NASDAQ:ATXI) Head-To-Head Comparison - Defense World
Blank check company Spartacus Acquisition Corp II files for IPO of 20 million units for $200 millionSEC filing - marketscreener.com
Aktis Oncology files for US IPO as biotech listings rebound - marketscreener.com
Vine Hill Capital Investment Corp. II Closes Initial Public Offering - marketscreener.com
Nasdaq Inc will be open as scheduled on Wednesday, December 24, 2025, and Friday, December 26, 2025 - marketscreener.com
Intellego board has asked Nasdaq to keep trading halted - marketscreener.com
Tradeweb CEO says round-the-clock trading to become mainstream - marketscreener.com
Alerts, brief on Cybin transferring US listing to Nasdaq withdrawn - marketscreener.com
Nasdaq sees bigger year ahead for listings on billion-dollar-plus IPOs - marketscreener.com
Ben strengthens balance sheet with over $1.24 million in liability reductions - marketscreener.com
Blank Check Co, Proem Acquisition Corp I files for IPO of up to $130 million - marketscreener.com
RTW Biotech invests USD5.9 million in Yarrow Bioscience funding round - marketscreener.com
Launchpad Cadenza Acquisition Corp I Prices IPO - marketscreener.com
SS Lazio, a global brand between the stock market and US ambitions - marketscreener.com
Wall St slips on losses in healthcare and energy stocks; focus on economic data - MarketScreener
Nasdaq seeks to extend trading hours to nearly round-the-clock - marketscreener.com
Bitcoin hoarding company Strategy remains in Nasdaq 100 - marketscreener.com
Nasdaq submits new plan with more power to block IPOs vulnerable to manipulation - marketscreener.com
Nasdaq seeks more power to block IPOs vulnerable to manipulation - marketscreener.com
Critical Survey: NexImmune (NASDAQ:NEXI) and Palatin Technologies (PINK:PTNT) - Defense World
Critical Review: NexImmune (NASDAQ:NEXI) and Eagle Pharmaceuticals (NASDAQ:EGRX) - Defense World
NexImmune (NASDAQ:NEXI) versus iBio (NYSE:IBIO) Financial Survey - Defense World
Head-To-Head Survey: NexImmune (NASDAQ:NEXI) versus Evotec (OTCMKTS:EVTCY) - Defense World
Central Bancompany valued at $5.26 billion in Nasdaq debut - marketscreener.com
Wall Street opens higher as Nvidia test looms - marketscreener.com
Sampo Gets Berenberg’s Vote As Nordic Insurance Leader - Finimize
Total debt per share of NexImmune, Inc. – LS:A3EUTV - TradingView
Evolution Global Acquisition Shares Rise in Nasdaq Debut - marketscreener.com
Digi: 'New & Novel' ETF Filings Need to Fit Listing Rules - marketscreener.com
EU Antitrust Watchdog Probes Deutsche Boerse, Nasdaq Over Financial Derivatives -- Update - marketscreener.com
BlackRock-backed TXSE Group adds US banking giant J.P. Morgan as investor - marketscreener.com
Gloo, with former Intel CEO Gelsinger as tech head, seeks nearly $900 million valuation in IPO - marketscreener.com
Clean Energy Technologies, Inc. regains compliance with Nasdaq listing requirements - marketscreener.com
Qt Imaging Holdings IncSubmits application to relist on Nasdaq - marketscreener.com
NexImmune, Inc. (NEXI) stock price, news, quote and history - Yahoo
Functional Brands expects common stock to begin trading on Nasdaq on or about November 4 - marketscreener.com
Book value per share of NexImmune, Inc. – LS:A3EUTV - TradingView
Neximmune Inc Stock (NEXI) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.12%
0.87%
Cap:
|
Volume (24h):